Search the web
Yahoo! NewsSign In
New User? Sign Up
Welcome, Guest Personalize News Home Page   -   Sign In
Yahoo! News   Fri, Jun 11, 2004
Search for    Advanced
News Home
Top Stories
U.S. National
   Weight Loss
   Sexual Health
Most Popular
Oddly Enough
News Photos
Most Popular
Full Coverage

Full Coverage
More about
Mental Health
Related News Stories
Panel to Review Electric Device for Depression Reuters via Yahoo! News (Jun 11, 2004)
Suffocation Suicides Rising Among Youth -- Study Reuters via Yahoo! News (Jun 10, 2004)
Medical Journal Urges Glaxo to Reveal Trial Results Reuters via Yahoo! News (Jun 10, 2004)
Opinion & Editorials
Pills for Depression Send the Wrong Signal at The Los Angeles Times (reg. req'd) (Jun 11, 2004)
Drug Up Your Teen Today! at San Francisco Chronicle (Jun 4, 2004)
Feature Articles
Pills or Talk Therapy? If You're Confused, No Wonder at The New York Times (reg. req'd) (Jun 8, 2004)
His Work Is Still Full of Life LA Times via Yahoo! News (Jun 5, 2004)
Related Web Sites
National Mental Illness Screening Project
Center for Mental Health Services - Knowledge Exchange Network

News Resources
· Reuters
· AP
· HealthDay
· ACS News Today
· CP
News Alerts
·News Alerts
 News via RSS

Health - Reuters
Medical Journal Urges Glaxo to Reveal Trial Results

Thu Jun 10, 7:22 PM ET
Add Health - Reuters to My Yahoo!

LONDON (Reuters) - A leading medical journal urged drugs giant GlaxoSmithKline on Friday to reveal all its research on the antidepressant Seroxat, which has been the subject of controversy on both sides of the Atlantic because of a possible increased risk of suicidal behavior in young patients.

Yahoo! Health
Have questions about your health?
Find answers here.


New York Attorney General Eliot Spitzer filed a suit last week, claiming Europe's largest drugmaker withheld negative information about treating children and teenagers with the drug, which is also known as paroxetine and sold in the United States under the name Paxil.

Glaxo has denied the allegations and says it had acted responsibly.

But in an editorial, The Lancet medical journal said the company had sponsored at least five studies that tested the drug's efficacy in children but only one, which had mixed results, has been published.

"If GSK has nothing to hide, as it claims, it should open the files before being ordered to do so by a court -- and do so right now," the journal said.

It added that the disclosure of the results had been limited to the Federal Drug Agency (FDA (news - web sites)) in the United States and other regulatory agencies. But doctors and consumers needed the information to make informed decisions.

Many researchers and journals have argued that all clinical trials should be registered and all results published.

"But as the lawsuit pointedly demonstrates, the time has come for these matters to be revealed in a bright and public light," the journal added.

Spitzer, who filed the suit in the New York State Supreme Court in Manhattan, demands Glaxo give up all profits from the sale of the drug in New York for treating depression in children and teens. The suit also seeks unspecified damages.

The drug is not licensed in the United States or Europe for use by adolescents or children but "off label" prescribing for younger patients if a doctor thinks it could be beneficial is not uncommon.

The Lancet noted that the stakes are high.

"GSK's net income in 2002 was more than $6.9 billion, and in the first quarter of 2004, sales of paroxetine were $533 million," according to the journal.

2.1 million paroxetine prescriptions for children were written in the USA in 2002, it added.

Story Tools
Mail to Friend  Email Story
Message Boards   Post/Read Msgs (4)
Printer Version   Print Story  
Ratings: Would you recommend this story?
Not at all 1 - 2 - 3 - 4 - 5 Highly
Tools Sponsored by: HP

Special Feature

Missed Tech Tuesday?
LCD and plasma TVs are getting bigger and cheaper, but which is better?

Prev. Story: Panel to Review Electric Device for Depression (Reuters)
Next Story: Sinus Headaches Often Really Migraines: Study (Reuters)

More Health Stories
· Stem Cells Not Alzheimer's Priority   (AP)
· Health Tip: Scheduled for Amniocentesis?  (HealthDay)
· Researchers Report Progress Against Lung Cancer  (American Cancer Society)
· WHO, UNAIDS welcome G8 endorsement for virtual consortium  (AFP)
· Panel to Review Electric Device for Depression  (Reuters)


Online Graduate Degrees in Health
Online Graduate Degrees in Health
Browse All Health Programs
from Yahoo! Education

Copyright (c) 2004 Reuters Limited. All rights reserved. Republication or redistribution of Reuters content is expressly prohibited without the prior written consent of Reuters. Reuters shall not be liable for any errors or delays in the content, or for any actions taken in reliance thereon.
Copyright © 2004 Yahoo! Inc. All rights reserved.
Questions or Comments
Privacy Policy -Terms of Service - Copyright Policy - Ad Feedback